Decreased hepatic insulin extraction precedes overt noninsulin dependent (Type II) diabetes in obese monkeys.
Many obese middle-aged rhesus monkeys (Macaca mulatta) spontaneously develop noninsulin dependent diabetes mellitus (NIDDM). Basal hyperinsulinemia and increased stimulated plasma insulin levels are associated with this obesity and precede the onset of overt diabetes. The present studies sought to determine the relative contributions of enhanced insulin secretion and of reduced insulin clearance to this early obesity-associated hyperinsulinemia. Direct simultaneous measurement of portal and jugular vein insulin levels in two normal monkeys showed a constant rate of hepatic insulin extraction of 56+/-3% over the range of peripheral insulin levels from 351+/-113 to 625+/-118 pmol/L. In 33 additional monkeys ranging from normal to diabetic, basal C-peptide levels were examined as an indicator of beta-cell secretion and the molar ratio of plasma C-peptide to insulin (C/I ratio) under basal steady state conditions calculated as an index of hepatic insulin extraction. Well in advance of overt diabetes, there was a progressive decline of 67% in the apparent hepatic insulin extraction rate in association with increased obesity and plasma insulin levels. Basal insulin levels and hepatic insulin extraction returned toward normal in monkeys with impaired glucose tolerance and in those with overt diabetes. We conclude that reduced insulin disposal, probably due to reduced hepatic extraction of insulin, in addition to increased beta-cell activity, contributes to the development of basal hyperinsulinemia in obese rhesus monkeys progressing toward NIDDM. In addition, in overt diabetes, normal hepatic insulin extraction in the presence of limited beta-cell secretion may exacerbate the hypoinsulinemic state.
Hansen
B C
BC
Department of Physiology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA.
Striffler
J S
JS
Bodkin
N L
NL
D000273:Adipose Tissue; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002096:C-Peptide / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000473:pathology; D004195:Disease Models, Animal; D005260:Female; D005951:Glucose Tolerance Test; D006946:Hyperinsulinism / Q000473:pathology; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D050417:Insulin-Secreting Cells / Q000378:metabolism; D007601:Jugular Veins / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008253:Macaca mulatta; D008297:Male; D008659:Metabolic Diseases / Q000378:metabolism; D009765:Obesity / Q000473:pathology*; D011169:Portal Vein / Q000378:metabolism; D011972:Receptor, Insulin; D013997:Time Factors
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D011972:Receptor, Insulin